NDRA looking good. "full commercial launch in the 2019". Pretty rare to find such a low MC biotech w/near term potential for commercial launch. also Catalysts near term ( a week to weeks) $NDRA If everything works as planned,this is a billion dollar company in about a year. commercial liver product in Europe in 2019 with support from our partner GE. NAFLD affects over 1 billion people globally and is estimated to cost the U.S healthcare system over $100B annually
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.